Maria Julia Lemos

Dr. Maria Julia Lemos

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2026 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
LQLaura Fonseca Queiroz
Laura Fonseca Queiroz
MLMaria Julia Lemos
Maria Julia Lemos
BABruna Benigna Sales Armstrong
Bruna Benigna Sales Armstrong
PŁPaweł Łajczak
Paweł Łajczak
GMGiovanna Cristina de Castro Martin
Giovanna Cristina de Castro Martin
RRRodrigo Ruano
Rodrigo Ruano

1 March 2026 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Open access
JOJuliana Almeida Oliveira
Juliana Almeida Oliveira
MLMaria Julia Lemos
Maria Julia Lemos
YDYasmin Jardim Meirelle Dias
Yasmin Jardim Meirelle Dias
LQLaura Fonseca Queiroz
Laura Fonseca Queiroz
ASAna Clara Pimenta Servidoni
Ana Clara Pimenta Servidoni
LALinda Aljunaid
Linda Aljunaid
This meta-analysis aimed to evaluate the effectiveness of adding postoperative oral cephalexin and metronidazole to standard preoperative prophylaxis in preventing surgical site infections (SSI) among obese women undergoing cesarean delivery. We systematically searched PubMed, EMBASE, and Cochrane Central Register of Controlled Trials for randomized controlled trials. Studies involving obese women undergoing cesarean delivery with the intervention of postoperative oral cephalexin plus metronidazole were included. Data were analyzed using a random-effects model to pool risk ratios (RRs) with 95% confidence intervals (CIs). Three randomized controlled trials, encompassing 1144 patients, were included. The pooled analysis revealed that postoperative oral cephalexin and metronidazole significantly reduced the incidence of cellulitis (RR 0.50; 95% CI 0.28-0.89; p = 0.01). However, no statistically significant differences were found for other outcomes, including wound separation (RR 0.68; 95% CI 0.40-1.14), fever (RR 0.49; 95% CI 0.08-3.01), composite SSI (RR 0.55; 95% CI 0.29-1.05), endometritis (RR 0.49; 95% CI 0.13-1.94), or wound seroma (RR 0.9; 95% CI 0.51-1.57). Sensitivity analysis indicated the significance for cellulitis was sensitive to individual studies. In conclusion, the addition of postoperative oral cephalexin and metronidazole reduces cellulitis incidence in obese women following cesarean section. While a broader impact on other surgical site infections was not observed, this targeted benefit for cellulitis suggests a potential role as an adjunct to current prophylaxis. Further robust research is needed to validate these findings and refine preventive strategies.